Evaluation of a Novel Antiplatelet Therapy Strategy in Patients Undergoing Elective Percutaneous Coronary Intervention.
Kayla GiangHolly E StallingsPaul CloptonMaria K StubbsWilliam F PennyPublished in: Journal of pharmacy practice (2020)
In DAPT-naive patients undergoing elective PCI for SIHD, a strategy of in-lab ticagrelor transitioning to clopidogrel with a 300-mg load was not associated with increased bleeding or other adverse events.
Keyphrases
- antiplatelet therapy
- patients undergoing
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- atrial fibrillation
- coronary artery bypass grafting
- coronary artery bypass
- hiv infected